TFDP1 activates SPC25-mediated glutamine metabolism to repress anti-tumor immunity of NK cells in lung adenocarcinoma
This study intended to verify the inhibitory effect of TFDP1 on NK cell anti-tumor immunity by activating SPC25-mediated LUAD glutamine metabolism.
Authors
- Jianyang Ding (ORCID: https://orcid.org/0000-0001-8337-4179)
- Zhangyong Yin
- Congxiong Peng (ORCID: https://orcid.org/0000-0002-2844-2287)
- Mingjiang Huang (ORCID: https://orcid.org/0000-0003-1856-689X)
- Keng Chen (ORCID: https://orcid.org/0000-0002-1198-8005)
- Gongzhi Wu (ORCID: https://orcid.org/0000-0002-3767-1364)
- Wei He (ORCID: https://orcid.org/0000-0003-0161-3274)
- Xuhui Wu (ORCID: https://orcid.org/0000-0002-0050-8483)
- Bin Huang (ORCID: https://orcid.org/0000-0002-0944-7648)
- Xuyang Peng
Institutions
- Hangzhou Normal University (CN)
- Lishui City People's Hospital (CN)
Publication Details
- Journal
- Expert Review of Clinical Immunology
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1080/1744666x.2025.2524469
- Citations
- 2
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 1.87